 |
|
Cost-Related Medication Underuse
Do Patients With Chronic Illnesses Tell Their Doctors?
John D. Piette, PhD;
Michele Heisler, MD, MPA;
Todd H. Wagner, PhD
Arch Intern Med. 2004;164:1749-1755.
Background Although many chronically ill patients underuse prescription medications because of cost concerns, we know little about their discussions with clinicians about this issue.
Methods Nationwide survey of 660 older adults with chronic illnesses who reported underusing medication in the prior year because of cost. We assessed whether patients discussed cost-related medication underuse with clinicians, reasons that some patients did not talk with clinicians about this problem, how clinicians responded when this issue was raised, and how helpful patients perceived clinicians to be.
Results Two thirds of respondents never told a clinician in advance that they planned to underuse medication because of the cost, and 35% never discussed the issue at all. Of those who did not tell a clinician, 66% reported that nobody asked them about their ability to pay for prescriptions and 58% reported that they did not think providers could help them. When patients talked with clinicians about medication costs, 72% found those conversations helpful. However, 31% reported that their medications were never changed to a generic or less expensive alternative, and few patients were given other forms of assistance such as information about programs that help pay drug costs (30%) or where to purchase less expensive medication (28%). Patients were most likely to find clinicians helpful if clinicians provided free samples, asked about problems paying for prescriptions, and offered advice about how to pay for patients' current regimens.
Conclusions About one third of chronically ill adults who underuse prescription medication because of the cost never talk with clinicians in advance, and many never raise this issue at all. Clinicians should take a more proactive role in identifying and assisting patients who have problems paying for prescription drugs.
From the Department of Veterans Affairs Center for Practice Management and Outcomes Research, and Department of Internal Medicine, University of Michigan, Ann Arbor (Drs Piette and Heisler); and the Department of Veterans Affairs Health Economics Resource Center, and Department of Health Research and Policy, Stanford University, Palo Alto, Calif (Dr Wagner). The authors have no relevant financial interest in this article.
RELATED ARTICLE
Don't Ask, Don't Tell: The Status of Doctor-Patient Communication About Health Care Costs
Alex D. Federman
Arch Intern Med. 2004;164(16):1723-1724.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Beneath the surface: discovering the unvoiced concerns of older adults with Type 2 diabetes mellitus
Tjia et al.
Health Educ Res 2008;23:40-52.
ABSTRACT
| FULL TEXT
Race/Ethnicity and Economic Differences in Cost-Related Medication Underuse Among Insured Adults With Diabetes: The Translating Research Into Action for Diabetes Study
Tseng et al.
Diabetes Care 2008;31:261-266.
ABSTRACT
| FULL TEXT
Depression and Cost-Related Medication Nonadherence in Medicare Beneficiaries
Bambauer et al.
Arch Gen Psychiatry 2007;64:602-608.
ABSTRACT
| FULL TEXT
Food Insecurity Among Cancer Patients in Kentucky: A Pilot Study
Simmons et al.
J Oncol Pract 2006;2:274-279.
ABSTRACT
| FULL TEXT
Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.
Soumerai et al.
Arch Intern Med 2006;166:1829-1835.
ABSTRACT
| FULL TEXT
Patient-reported underuse of prescription medications: a comparison of nine surveys.
Kirking et al.
Med Care Res Rev 2006;63:427-446.
ABSTRACT
Medication access through patient assistance programs.
Chauncey et al.
Am J Health Syst Pharm 2006;63:1254-1259.
FULL TEXT
Frequent Outpatient Contact and Decreasing Medication Affordability in Patients With Diabetes From 1997 to 2004.
Grant et al.
Diabetes Care 2006;29:1386-1388.
FULL TEXT
Medicare Coverage of Tumor Necrosis Factor {alpha} Inhibitors as an Influence on Physicians' Prescribing Behavior
DeWitt et al.
Arch Intern Med 2006;166:57-63.
ABSTRACT
| FULL TEXT
National Trends in Cyclooxygenase-2 Inhibitor Use Since Market Release: Nonselective Diffusion of a Selectively Cost-effective Innovation
Dai et al.
Arch Intern Med 2005;165:171-177.
ABSTRACT
| FULL TEXT
Patients with Chronic Illnesses Underuse Medications Because of Cost
Robbins
AAP Grand Rounds 2005;13:6-6.
FULL TEXT
Don't Ask, Don't Tell: The Status of Doctor-Patient Communication About Health Care Costs
Federman
Arch Intern Med 2004;164:1723-1724.
FULL TEXT
|
